Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Panelists discuss the current and future roles of advanced treatments, including biologics and Bruton tyrosine kinase (BTK) inhibitors, in the management of chronic spontaneous urticaria (CSU), highlighting their potential to improve patient outcomes and the evolving landscape of treatment options.
Africa sees third wave as only 1% of the population is fully vaccinated.
Barry A. Borlaug, MD describes the beneficial effect of tirzepatide on circulatory pressure-volume overload and end-organ damage in patients with HFpEF and obesity.
Announced on May 12, 2023, the FDA's approval of fezolinetant (Veozah) marks their first approval for an NK3 receptor antagonist for the treatment of vasomotor symptoms of menopause.
Drs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.
A panel of expert cardiologists share their clinical pearls for managing patients with hyperlipidemia.
Drs James Januzzi, Javed Butler, Robert Mentz, and Muthiah Vaduganathan share practice pearls for treating patients with heart failure, focusing on the future of treatment.
Experts look into what is next for sickle cell disease and provide key thoughts on the space.
Medical experts share their final thoughts on the future of atopic dermatitis treatment with oral systemic agents.
Dr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
The panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.
An expert reviews the updated recommendations of the American College of Gastroenterology guidelines on the evaluation and management of celiac disease.
Key opinion leaders conclude their discussion on plaque psoriasis by commenting on the potential for research into the genetic origin of disease, possible biomarkers, and treatment options with greater efficacy.
Cheung comments on new and future IgAN treatment, and shares clinical pearls with other providers.
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, interview Scott Kahan, MD, MPH who serves on the committee that creates the ADA Standards of Care in Diabetes, to discuss the latest updates in weight management guidelines.
Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.
Gerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
ADHD experts share their final thoughts on the treatment and management of ADHD.
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Experts conclude this series highlighting what is on the horizon of retinal disease care.
Drs Arun Jesudian and James William discuss approaches for proper discharge planning and transition of care and how this can reduce readmission for patients with hepatic encephalopathy.
Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
The panel offers their final recommendations for physicians managing patients with asthma.
A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
The panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.